Sunscreening agents: A review

Journal of Clinical and Aesthetic Dermatology

Volumn 6, Issue 1, 2013, Pages 16-26

  Latha, M S ^a   Martis, Jacintha ^b   Shobha, V ^b   Shinde, Rutuja Sham ^a   Bangera, Sudhakar ^c   Krishnankutty, Binny ^d   Bellary, Shantala ^a   Varughese, Sunoj ^a   Rao, Prabhakar ^a   Kumar, B R Naveen ^a  

^a DR REDDY'S LABORATORIES LTD   (India)

^b FATHER MULLER MEDICAL COLLEGE   (India)

^c Clinical Research   (India)

^d Azeezia Medical College   (India)

Author keywords

[No Author keywords available]

Indexed keywords

3 (4 METHYLBENZYLIDENE)CAMPHOR; 4 DIMETHYLAMINOBENZOIC ACID 2 ETHYLHEXYL ESTER; 4 METHOXYCINNAMIC ACID 2 ETHYLHEXYL ESTER; ANTHRANILIC ACID METHYL ESTER; ANTIMALARIAL AGENT; ASCORBIC ACID; AVOBENZONE; BEMOTRIZINOL; BENZOPHENONE; BETA CAROTENE; BISDISULIZOLE DISODIUM; BISOCTRIZOLE; CINNAMIC ACID DERIVATIVE; DIETHYLTOLUAMIDE; DIOXYBENZONE; ECAMSULE; ENSULIZOLE; ICHTHAMMOL; IRON OXIDE; KAOLIN; MERADIMATE; OCTOCRYLENE; OXYBENZONE; SALICYLIC ACID DERIVATIVE; SULISOBENZONE; SUNSCREEN; TALC; TITANIUM DIOXIDE; UNINDEXED DRUG; ZINC OXIDE;

ANTIOXIDANT ACTIVITY; ASIAN; AUSTRALIA; BASAL CELL CARCINOMA; CANCER RISK; DRUG ABSORPTION; DRUG APPROVAL; DRUG EFFICACY; DRUG EXCRETION; DRUG FORMULATION; DRUG MECHANISM; DRUG PENETRATION; DRUG SAFETY; DRUG TREATMENT FAILURE; FOOD AND DRUG ADMINISTRATION; GENE EXPRESSION; HEALTH HAZARD; HUMAN; IMMUNITY; INDIA; JAPAN; KOREA; NEW ZEALAND; PATIENT EDUCATION; PHOTOTOXICITY; PHYSICAL ACTIVITY; PIGMENTATION; PRACTICE GUIDELINE; REVIEW; SAFETY; SKIN CARCINOMA; SKIN DEFECT; SKIN IRRITATION; SKIN PENETRATION; STRATUM CORNEUM; SUN EXPOSURE; ULTRAVIOLET A RADIATION; ULTRAVIOLET B RADIATION; WRINKLE;

EID: 84872314431     PISSN: 19412789     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (79)

1. Yuan C, Wang XM, Tan YM, et al. Effects of sunscreen on human skin's ultraviolet radiation tolerance. J Cosmet Dermatol. 2010;9:297-301.
2. DeBuys HV, Levy SB, Murray JC, et al. Modern approaches to photoprotection. Dermatol Clin. 2000;18:577-590.
3. Ortel B, Tanew A, Wolff K, Hönigsmann H. Polymorphous light eruption: action spectrum and photoprotection. J Am Acad Dermatol. 1986;14:748-753. (Pubitemid 16113966)
4. Miyamoto C. Polymorphous light eruption: successful reproduction of skin lesions, including papulovesicular light eruption, with ultraviolet B. Photodermatol. 1989;6:69-79. (Pubitemid 19152210)
5. Ryckaert S, Roelandts R. Solar urticaria. A report of 25 cases and difficulties in phototesting. Arch Dermatol. 1998;134:71-74. (Pubitemid 28087116)
6. Stoebner PE, Poosti R, Djoukelfit K, Martinez J, Meunier L. Decreased human epidermal antigen-presenting cell activity after ultraviolet A exposure: dose-response effects and protection by sunscreens. Br J Dermatol. 2007;156:1315-1320. (Pubitemid 47029831)
7. Wang SQ, Setlow R, et al. Ultraviolet A and melanoma: a review. J Am Acad Dermatol. 2001:837-846. (Pubitemid 32391174)
8. Buller DB, Cokkinides V, Hall HI, et al. Prevalence of sunburn, sun protection, and indoor tanning behaviors among Americans: review from national surveys and case studies of 3 states. J Am Acad Dermatol. 2011;65:S114-S123.
9. Rodvall YE, Wahlgren CF, Ullén HT, Wiklund KE. Factors related to being sunburnt in 7-year-old children in Sweden. Eur J Cancer. 2010;46:566-572.
10. Diffey BL. Sunscreens as a preventative measure in melanoma: an evidence-based approach or the precautionary principle? Br J Dermatol. 2009;161:25-27.
11. Diffey BL. The impact of topical photoprotectants intended for daily use on lifetime ultraviolet exposure. J Cosmet Dermatol. 2011;10:245-250
12. Kaimal S, Abraham A. Sunscreens. Indian J Dermatol Venereol Leprol. 2011;77:238-243.
13. Lademann J, Schanzer S, Jacobi U, et al. Synergy effects between organic and inorganic UV filters in sunscreens. J Biomed Opt. 2005;10:14008.
14. Vergou T, Patzelt A, Richter H, et al. Transfer of ultraviolet photon energy into fluorescent light in the visible path represents a new and efficient protection mechanism of sunscreens. J Biomed Opt. 2011;16:105001
15. Meinke MC, Haag SF, Schanzer S, et al. Radical protection by sunscreens in the infrared spectral range. Photochem Photobiol. 2011;87:452-456
16. Marionnet C, Grether-Beck S, Seité S, et al. A broad-spectrum sunscreen prevents UVA radiation-induced gene expression in reconstructed skin in vitro and in human skin in vivo. Exp Dermatol. 2011;20:477-482.
17. Chen T, Burczynski FJ, Miller DW, Gu X. Percutaneous permeation comparison of repellents picaridin and DEET in concurrent use with sunscreen oxybenzone from commercially available preparations. Pharmazie. 2010;65:835-839.
18. Giacomoni PU, Teta L, Najdek L. Sunscreens: the impervious path from theory to practice. Photochem Photobiol Sci. 2010;9:524-529.
19. Medeiros VL, Lim HW. Sunscreens in the management of photodermatoses. Skin Therapy Lett. 2010;15:1-3.
20. Rai R, Srinivas CR. Photoprotection. Indian J Dermatol Venereol Leprol. 2007;73(2):73-79. (Pubitemid 46675028)
21. Singhal M, Khanna S, Nasa A. Cosmeceuticals for the skin: an overview. Asian J Pharm Clin Res. 2011;4:16.
22. Bodekaer M, Faurschou A, Philipsen PA, Wulf HC. Sun protection factor persistence during a day with physical activity and bathing. Photodermatol Photoimmunol Photomed. 2008;24:296-300.
23. Schalka S, dos Reis VM, Cucé LC. The influence of the amount of sunscreen applied and its sun protection factor (SPF): evaluation of two sunscreens including the same ingredients at different concentrations. Photodermatol Photoimmunol Photomed. 2009;25:175-180.
24. Kim SM, Oh BH, Lee YW, et al. The relation between the amount of sunscreen applied and the sun protection factor in Asian skin. J Am Acad Dermatol. 2010;62:218-222.
25. Stanfield JW. Proposed method for assesstng sunscreen photostabtlity and broad spectrum protection. Docket No. 78N-0038. Dated 5 Sept 2005. http://www.fda.gov/ohrms/dockets/dailys/00/Sep00/090700/c000574.pdf. Accessed September 12, 2012.
26. Kaidbey K, Barnes A. Determination of WA protection factors by means of immediate pigment darkening in normal skin. J Am Acad Dermatol. 1991;25:262-266.
27. Fitzpatrick TB. The validity and practicality of sun-reactive skin types I through VI. Arch Dermatol. 1988;124:869-871.
28. Matts PJ, Alard V, Brown MW, et al. The COLIPA in vitro UVA method: a standard and reproducible measure of sunscreen UVA protection. Int J Cosmet Sci. 2010;32:35-46.
29. Guidance for Industry. Enforcement Policy - OTC Sunscreen Drug Products Marketed Without an Approved Application. http://www.fda.gov/downloads/Drugs/ GuidanceComplianceRegulatoryInformation/Guidances/UCM259001.pdf. Updated June 2011. Accessed September 12, 2012.
30. Federal Register, Part IV. Department of Health and Human Services. Food and Drug Administration. 21 CFR Parts 201, 310, and 352. Sunscreen Drug Products for Over-the-Counter Human Use; Final Rules and Proposed Rules. June 17, 2011. http://www.gpo.gov/fdsys/pkg/FR-2011-06-17/pdf/2011-14766.pdf. Accessed November 15, 2012.
31. Commission recommendations of 22 September 2006 on the efficacy of sunscreen products and the claims made relating thereto (2006/647/EC). Official Journal of the European Union. 26.9.2006.265/39-265/43.
32. Recommendations from the European Commission. Federal Office of Public Health. Recommendations from European Commission. Updated March 16, 2009. http://www.bag.admin.ch/themen/lebensmittel/04861/05280/06242/index.html?lang= en. Accessed September 12, 2012.
33. Standards Australia. Media release. http://www.standards.org.au/ OurOrganisation/News/Documents. Updated June 14, 2012. http://www.standards.org. au/OurOrganisation/News/Documents/ 120613%20Sunscreen%20SPF%2050%20plus%20V2%20CS.pdf Accessed July 26, 2012.
34. Appendix 3: JCIA persistent pigment darkening protocol. http://www.fda.gov/ohrms/dockets/dailys/00/Sep00/090600/c000565-appendix-03.pdf. Accessed July 26, 2012.
35. KFDA: Cosmetics. Evaluation of sun protection effects. http://www.kfda.go.kr/eng/eng/index.do;jsessionid= mA2u578F9n89nYaF8nXqg88afBkajbKvsalw0ZyzInbbQi79ePrcn0eb31Hs67Tx?nMenuCode= 35&searchKeyCode=73&page=1&mode=view&boardSeq=66576. Accessed on July 26, 2012.
36. Scalia S, Mezzena M, Ramaccini D. Encapsulation of the UV filters ethylhexyl methoxycinnamate and butyl methoxydibenzoylmethane in lipid microparticles: effect on in vivo human skin permeation. Skin Pharmacol Physiol. 2011;24:182-189.
37. Gonzalez H, Farbrot A, Larkö O, Wennberg AM. Percutaneous absorption of the sunscreen benzophenone-3 after repeated whole-body applications, with and without ultraviolet irradiation. Br J Dermatol. 2006;154:337-340. (Pubitemid 43382707)
38. Gustavsson GH, Farbrot A, Larkö O. Percutaneous absorption of benzophenone-3, a common component of topical sunscreens. Clin Exp Dermatol. 2002;27:691-694. (Pubitemid 35454233)
39. Janjua NR, Kongshoj B, Andersson AM, Wulf HC. Sunscreens in human plasma and urine after repeated whole-body topical application. J Eur Acad Dermatol Venereol. 2008;22:456-461. (Pubitemid 351436917)
40. Janjua NR, Mogensen B, Andersson AM, et al. Systemic absorption of the sunscreens benzophenone-3, octyl-methoxycinnamate, and 3-(4-methyl-benzylidene) camphor after whole-body topical application and reproductive hormone levels in humans. J Invest Dermatol. 2004;123:57-61. (Pubitemid 38833463)
41. Wissing SA, Müller RH. Solid lipid nanoparticles as carrier for sunscreens: in vitro release and in vivo skin penetration. J Control Release. 2002;81:225-233. (Pubitemid 34607144)
42. 2 and ZnO nanoparticle percutaneous absorption. Skin Pharmacol Physiol. 2009;22:266-275.
43. Newman MD, Stotland M, Ellis JI. The safety of nanosized particles in titanium dioxide- and zinc oxide-based sunscreens. J Am Acad Dermatol. 2009;61:685-692.
44. Scalia S, Mezzena M, Iannuccelli V. Influence of solid lipid microparticle carriers on skin penetration of the sunscreen agent, 4-methylbenzylidene camphor. J Pharm Pharmacol. 2007;59:1621-1627. (Pubitemid 350221806)
45. Lacatusu I, Badea N, Murariu A, Meghea A. The encapsulation effect of UV molecular absorbers into biocompatible lipid nanoparticles. Nanoscale Res Lett. 2011;6:73.
46. Young AR, Boles J, Herzog B, et al. A sunscreen's labeled sun protection factor may overestimate protection at temperate latitudes: a human in vivo study. J Invest Dermatol. 2010;130:2457-2462.
47. Seité S, Fourtanier AM. The benefit of daily photoprotection. J Am Acad Dermatol. 2008;58:S160-S166. (Pubitemid 351503641)
48. Green A, Williams G, Neale R, et al. Daily sunscreen application and betacarotene supplementation in prevention of basal-cell and squamous-cell carcinomas of the skin: a randomised controlled trial. Lancet. 1999;354:723-729. (Pubitemid 29405786)
49. Kuhn A, Gensch K, Haust M, et al. Photoprotective effects of a broad-spectrum sunscreen in ultraviolet-induced cutaneous lupus erythematosus: a randomized, vehicle-controlled, double-blind study. J Am Acad Dermatol. 2011;64:37-48.
50. Hayden CG, Cross SE, Anderson C, et al. Sunscreen penetration of human skin and related keratinocyte toxicity after topical application. Skin Pharmacol Physiol. 2005;18:170-174. (Pubitemid 40869127)
51. Spijker GT, Schuttelaar ML, Barkema L, et al. Anaphylaxis caused by topical application of a sunscreen containing benzophenone-3. Contact Dermatitis. 2008;59:248-249.
52. Kaidbey KH, Agin PP, Sayre RM, Kligman AM. Photoprotection by melanin - a comparison of black and Caucasian skin. J Am Acad Dermatol. 1979;1:249-260. (Pubitemid 11159972)
53. Ulrich C, Degen A, Patel MJ, Stockfleth E. Sunscreens in organ transplant patients. Nephrol Dial Transplant. 2008;23:1805-1808. (Pubitemid 351768204)
54. Skiveren J, Mortensen EL, Haedersdal M. Sun protective behaviour in renal transplant recipients. A qualitative study based on individual interviews and the Health Belief Model. J Dermatolog Treat. 2010;21:331-336.
55. Gogna D, Jain SK, Yadav AK, Agrawal GP. Microsphere based improved sunscreen formulation of ethylhexyl methoxycinnamate. Current Drug Delivery. 2007;4:153-159. (Pubitemid 46557491)
56. Durand L, Habran N, Henschel V, Amighi K. In vitro evaluation of the cutaneous penetration of sprayable sunscreen emulsions with high concentrations of UV filters. Int J Cosmet Sci. 2009;31:279-292.
57. Wang SQ, Tooley IR. Photoprotection in the era of nanotechnology. Semin Cutan Med Surg. 2011;30:210-213.
58. Sharma V, Singh SK, Anderson D, et al. Zinc oxide nanoparticle induced genotoxicity in primary human epidermal keratinocytes. J Nanosci Nanotechnol. 2011;11:3782-3788.
59. Iavicoli I, Leso V, Fontana L, Bergamaschi A. Toxicological effects of titanium dioxide nanoparticles: a review of in vitro mammalian studies. Eur Rev Med Pharmacol Sci. 2011;15:481-508.
60. Tran DT, Salmon R. Potential photocarcinogenic effects of nanoparticle sunscreens. Australas J Dermatol. 2011;52:1-6.
61. Heng BC, Zhao X, Tan EC, et al. Evaluation of the cytotoxic and inflammatory potential of differentially shaped zinc oxide nanoparticles. Arch Toxicol. 2011;85:1517-1528.
62. Kerr A, Ferguson J. Photoallergic contact dermatitis. Photodermatol Photoimmunol Photomed. 2010;26:56-65.
63. Gorham ED, Mohr SB, Garland CF, et al. Do sunscreens increase risk of melanoma in populations residing at higher latitudes? Ann Epidemiol. 2007;17:956-963. (Pubitemid 350101231)
64. Autier P. Sunscreen abuse for intentional sun exposure. Br J Dermatol. 2009;161:40-45.
65. Autier P, Boniol M, Doré JF. Sunscreen use and increased duration of intentional sun exposure: Still a burning issue. Int J Cancer. 2007;121:1-5. (Pubitemid 46753845)
66. Wang SQ, Dusza SW, Lim HW. Safety of retinyl palmitate in sunscreens: a critical analysis. J Am Acad Dermatol. 2010;63:903-906.
67. Faurschou A, Beyer DM, Schmedes A, et al. The relation between sunscreen layer thickness and vitamin D production after UVB exposure - a randomised clinical trial. Br J Dermatol. 2012;167:391-395.
68. Agin PP, Ruble K, Hermansky SJ, McCarthy TJ. Rates of allergic sensitization and irritation to oxybenzone-containing sunscreen products: a quantitative meta-analysis of 64 exaggerated use studies. Photodermatol Photoimmunol Photomed. 2008;24:211-217.
69. Nanotechnology and sunscreens: environmental working group. EWG's 2009 Sunscreen Investigation. Washington DC, 2009. http://www.ewg.org/nanotechnology- sunscreens. Accessed June 12, 2012.
70. Buller DB, Andersen PA, Walkosz BJ, et al. Compliance with sunscreen advice in a survey of adults engaged in outdoor winter recreation at high-elevation ski areas. J Am Acad Dermatol. 2012;66:63-70.
71. Mahé E, Beauchet A, de Maleissye MF, Saiag P. Are sunscreens luxury products? J Am Acad Dermatol. 2011;65:e73-e79.
72. Al Robaee AA. Awareness to sun exposure and use of sunscreen by the general population. Bosn J Basic Med Sci. 2010;10:314-318.
73. Olson AL, Gaffney CA, Starr P, Dietrich AJ. The impact of an appearance-based educational intervention on adolescent intention to use sunscreen. Health Educ Res. 2008;23:763-769.
74. Haack RL, Horta BL, Cesar JA. Sunburn in young people: population-based study in Southern Brazil. Rev Saude Publica. 2008;42(1):26-33.
75. Robinson NG, White KM, Young RM, et al. Young people and sun safety: the role of attitudes, norms and control factors. Health Promot J Austr. 2008;19:45-51.
76. Uvinul A Plus [Product information]. BASF, the chemical company; 2012.
77. Geng J, Tang W, Wan X, et al. Photoprotection of bacterial-derived melanin against ultraviolet A-induced cell death and its potential application as an active sunscreen. J Eur Acad Dermatol Venereol. 2008;22:852-858. (Pubitemid 351837120)
78. Armstrong AW, Watson AJ, Makredes M, et al. Text-message reminders to improve sunscreen use: a randomized, controlled trial using electronic monitoring. Arch Dermatol. 2009;145:1230-1236.
79. Pustisek N, Lipozencic J, Ljubojevic S. A review of sunscreens and their adverse reactions. Acta Dermatovenerol Croat. 2005;13:28-35. (Pubitemid 41238171)